Mereo BioPharma Group PLC (MREO)
3.16
+0.11
(+3.61%)
USD |
NASDAQ |
May 01, 16:00
3.155
0.00 (0.00%)
After-Hours: 20:00
Mereo BioPharma Group Cash and Short Term Investments (Quarterly): 57.42M for Dec. 31, 2023
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 57.42M |
| June 30, 2023 | 53.12M |
| June 30, 2023 | 53.12M |
| December 31, 2022 | 68.18M |
| June 30, 2022 | 92.68M |
| June 30, 2022 | 92.68M |
| December 31, 2021 | 127.27M |
| June 30, 2021 | 152.37M |
| June 30, 2021 | 152.37M |
| December 31, 2020 | 31.98M |
| June 30, 2020 | 69.94M |
| June 30, 2020 | 69.94M |
| December 31, 2019 | 21.43M |
| Date | Value |
|---|---|
| June 30, 2019 | 45.77M |
| June 30, 2019 | 45.77M |
| December 31, 2018 | 34.95M |
| June 30, 2018 | 48.26M |
| June 30, 2018 | 48.26M |
| December 31, 2017 | 71.01M |
| June 30, 2017 | 73.61M |
| June 30, 2017 | 73.61M |
| December 31, 2016 | 66.10M |
| June 30, 2016 | 93.67M |
| June 30, 2016 | 93.67M |
| December 31, 2015 | 18.15M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
21.43M
Minimum
Dec 2019
152.37M
Maximum
Jun 2021
75.60M
Average
68.18M
Median
Dec 2022
Cash and Short Term Investments (Quarterly) Benchmarks
| Adaptimmune Therapeutics PLC | 146.94M |
| Biodexa Pharmaceuticals Plc | 7.606M |
| NuCana PLC | 21.94M |
| TC BioPharm (Holdings) PLC | 3.137M |
| Autolus Therapeutics PLC | 239.57M |